Catheter Precision Announces That New Clinical Data From The VIVO EU Registry Was Presented Last Week At The Society Of Cardiac Robotic Navigation Meeting; 17 (≈95%) Patients Had Successful Ablation Procedures; 83% Of Patients Had No Recurrence Of The...

Catheter Precision宣佈VIVO EU註冊數據新的臨床數據上週在心臟機器導航協會會議上發佈；17（約95%）患者成功進行消融手術；83%的患者沒有復發。

Benzinga · 2024/11/04 21:42

Catheter Precision Announces That New Clinical Data From The VIVO EU Registry Was Presented Last Week At The Society Of Cardiac Robotic Navigation Meeting; 17 (≈95%) Patients Had Successful Ablation Procedures; 83% Of Patients Had No Recurrence Of The Arrhythmia At 12 Months Post Ablation

Catheter Precision宣佈VIVO EU登記處的新臨床數據上週在心臟機器人導航學會上報告;17 (≈95%)名患者成功進行了消融手術; 83%的患者在消融手術後12個月沒有心律失常復發

Catheter Precision, Inc. (NYSE:VTAK), a U.S.-based innovative medical device company, today announced that new clinical data from the VIVO EU Registry was presented last week at the Society of Cardiac Robotic Navigation (SCRN) meeting in Lisbon, Portugal.

總部位於美國的醫療器械公司Catheter Precision, Inc. (紐交所: VTAK) 今天宣佈，VIVO EU登記處的新臨床數據上週在葡萄牙里斯本的心臟機器人導航學會上報告。

As previously announced, there were three presentations about VIVO during the SCRN meeting which took place October 28-29. The presentation by Professor Leonor Parreira shared the final data from Hospital da Luz. This center enrolled 27 subjects of which 18 proceeded with an ablation procedure with the following results:

正如之前宣佈的那樣，在10月28日至29日舉行的SCRN會議上有三個關於VIVO的演示。Leonorr Parreira教授的演示分享了醫院da Luz的最終數據。該中心招募了27名受試者，其中18名進行了消融手術，以下是結果：

100% accurate identification of the site of origin to the exact or neighboring cardiac segment

100%準確地確定發源地點爲精確或相鄰的心臟段

17 (≈95%) patients had successful ablation procedures

17名（約95%）患者的消融手術取得成功

83% of patients had no recurrence of the arrhythmia at 12 months post ablation

83%的患者在消融手術後12個月沒有心律失常的復發

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。

Catheter Precision Announces That New Clinical Data From The VIVO EU Registry Was Presented Last Week At The Society Of Cardiac Robotic Navigation Meeting; 17 (≈95%) Patients Had Successful Ablation Procedures; 83% Of Patients Had No Recurrence Of The...

Catheter Precision Announces That New Clinical Data From The VIVO EU Registry Was Presented Last Week At The Society Of Cardiac Robotic Navigation Meeting; 17 (≈95%) Patients Had Successful Ablation Procedures; 83% Of Patients Had No Recurrence Of The...

Catheter Precision Announces That New Clinical Data From The VIVO EU Registry Was Presented Last Week At The Society Of Cardiac Robotic Navigation Meeting; 17 (≈95%) Patients Had Successful Ablation Procedures; 83% Of Patients Had No Recurrence Of The Arrhythmia At 12 Months Post Ablation

Catheter Precision Announces That New Clinical Data From The VIVO EU Registry Was Presented Last Week At The Society Of Cardiac Robotic Navigation Meeting; 17 (≈95%) Patients Had Successful Ablation Procedures; 83% Of Patients Had No Recurrence Of The Arrhythmia At 12 Months Post Ablation

Catheter Precision宣佈VIVO EU登記處的新臨床數據上週在心臟機器人導航學會上報告;17 (≈95%)名患者成功進行了消融手術; 83%的患者在消融手術後12個月沒有心律失常復發

風險及免責聲明

聲明